Nardou, K.; Nicolas, M.; Kuttler, F.; Cisarova, K.; Celik, E.; Quinodoz, M.; Riggi, N.; Michielin, O.; Rivolta, C.; Turcatti, G.;
et al. Identification of New Vulnerabilities in Conjunctival Melanoma Using Image-Based High Content Drug Screening. Cancers 2022, 14, 1575.
https://doi.org/10.3390/cancers14061575
AMA Style
Nardou K, Nicolas M, Kuttler F, Cisarova K, Celik E, Quinodoz M, Riggi N, Michielin O, Rivolta C, Turcatti G,
et al. Identification of New Vulnerabilities in Conjunctival Melanoma Using Image-Based High Content Drug Screening. Cancers. 2022; 14(6):1575.
https://doi.org/10.3390/cancers14061575
Chicago/Turabian Style
Nardou, Katya, Michael Nicolas, Fabien Kuttler, Katarina Cisarova, Elifnaz Celik, Mathieu Quinodoz, Nicolo Riggi, Olivier Michielin, Carlo Rivolta, Gerardo Turcatti,
and et al. 2022. "Identification of New Vulnerabilities in Conjunctival Melanoma Using Image-Based High Content Drug Screening" Cancers 14, no. 6: 1575.
https://doi.org/10.3390/cancers14061575
APA Style
Nardou, K., Nicolas, M., Kuttler, F., Cisarova, K., Celik, E., Quinodoz, M., Riggi, N., Michielin, O., Rivolta, C., Turcatti, G., & Moulin, A. P.
(2022). Identification of New Vulnerabilities in Conjunctival Melanoma Using Image-Based High Content Drug Screening. Cancers, 14(6), 1575.
https://doi.org/10.3390/cancers14061575